Phase I/II Study of the Safety, Efficacy and Dose Evaluation of ProSavin for the Treatment of Bilateral Idiopathic Parkinson's Disease
Clinical trial NCT00627588 · COMPLETED
Trial details
- NCT number
- NCT00627588
- Sponsor
- Oxford BioMedica
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2012-08-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.